ISSN: 2329-9495
+44 1478 350008
Department of Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310014, China
Review Article
Randomized Controlled Trials of Ginkgo Ketone Ester Dropping Pills as Adjuvant Therapy for Coronary Heart Disease Angina: A Systematic Review and Meta-Analysis
Author(s): Xiao-Min Xue*, Ying-Zhi Chen, Shi-Yong Chen, Yu Li, Jie Wang, Hui-Fang Zhou, Si-Si Chen and Ren- Zhao Wu
Objective: Coronary Heart Disease (CHD) is one of the most common cardiovascular diseases in clinic. Ginkgo biloba Ketone Ester Dripping Pill (GKEDP) is a kind of Chinese patent medicine mainly developed by Ginkgo biloba ketone ester, widely used in treating cardiovascular diseases. This study aimed to evaluate the efficacy and safety of GKEDP combined with conventional drug therapy in the treatment of Coronary Heart Disease Angina (CHDA).
Methods: Chinese and foreign literature databases were searched by computer, and all the clinical research literature of GKEDP combined with Conventional drug therapy in treating CHDA were collected. The publication time was from the establishment of the database to September 1, 2020, without language restriction, and the type of literature was limited to Randomized Controlled Trials (RCT.. View More»
DOI:
10.35841/2329-9495.24.12.478